Calliditas Therapeutics AB (CALT)
40.00
0.00 (0.00%)
USD |
NASDAQ |
Sep 27, 16:00
Calliditas Therapeutics Total Assets (Quarterly): 164.63M for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 164.63M |
| March 31, 2024 | 158.48M |
| December 31, 2023 | 184.69M |
| September 30, 2023 | 147.67M |
| June 30, 2023 | 157.39M |
| December 31, 2022 | 187.38M |
| September 30, 2022 | 136.31M |
| June 30, 2022 | 142.72M |
| March 31, 2022 | 145.56M |
| December 31, 2021 | 161.37M |
| September 30, 2021 | 201.14M |
| June 30, 2021 | 144.58M |
| March 31, 2021 | 159.07M |
| Date | Value |
|---|---|
| December 31, 2020 | 178.77M |
| September 30, 2020 | 160.63M |
| June 30, 2020 | 159.49M |
| March 31, 2020 | 78.22M |
| December 31, 2019 | 90.45M |
| September 30, 2019 | 85.95M |
| June 30, 2019 | 76.23M |
| March 31, 2019 | 65.12M |
| December 31, 2018 | 72.21M |
| September 30, 2018 | 77.41M |
| June 30, 2018 | 7.382M |
| March 31, 2018 | 6.839M |
| December 31, 2017 | 7.617M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
78.22M
Minimum
Mar 2020
201.14M
Maximum
Sep 2021
153.25M
Average
158.77M
Median
Total Assets (Quarterly) Benchmarks
| Abliva AB | 7.132M |
| NuCana PLC | 25.38M |
| Karolinska Development AB | 117.25M |
| Oncopeptides AB | 27.02M |
| TC BioPharm (Holdings) PLC | 9.171M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 154.56M |
| Shareholders Equity (Quarterly) | 10.06M |
| Debt to Equity Ratio | 9.200 |
| Current Ratio | 2.686 |
| Net Debt Paydown Yield | -1.76% |